Stock Analysts’ new coverage for Tuesday, May 16th: StockNews.com assumed coverage on shares of ATA Creativity Global (NASDAQ:AACG). They issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). StockNews.com issued a hold rating on the stock. StockNews.com began coverage on shares of ADDvantage Technologies Group (NASDAQ:AEY). They issued […]
StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a report issued on Monday morning. The brokerage issued a hold rating on the stock. A number of other research analysts have also recently commented on JNCE. Piper Sandler cut shares of Jounce Therapeutics from an overweight rating to a neutral rating […]
StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report released on Monday morning. The brokerage issued a hold rating on the stock. Several other research firms have also issued reports on JNCE. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in a report […]
The PD-1 and PD-L1 inhibitors market is anticipated to be driven in the coming years due to the rise in novel drugs and therapies and the increase in healthcare spending across the world. In
Stock analysts at StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock. JNCE has been the subject of several other reports. Piper Sandler cut Jounce Therapeutics from an “overweight” rating to a […]